STAAR Surgical
STAA
170 hedge funds and large institutions have $904M invested in STAAR Surgical in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 33 closing their positions.
82% more call options, than puts
Call options by funds: $2.83M | Put options by funds: $1.55M
16% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 57
2.82% more ownership
Funds ownership: 105.93% → 108.74% (+2.8%)
2% less capital invested
Capital invested by funds: $922M → $904M (-$17.4M)
8% less funds holding
Funds holding: 185 → 170 (-15)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
39% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadwood Capital
New York
|
+$18.8M |
| 2 |
Morgan Stanley
New York
|
+$9.76M |
| 3 |
YC
Yunqi Capital
Hong Kong
|
+$8.35M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.44M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$6.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$18.1M |
| 2 |
BlackRock
New York
|
-$6.64M |
| 3 |
Goldman Sachs
New York
|
-$6.39M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$6.25M |
| 5 |
ACM
American Capital Management
New York
|
-$3.97M |
STAA Hedge Fund Activity: Q2 2025 in Review
170 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q2 2025, worth a combined $904M — down 1.9% from $922M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of STAA and 20 opened new positions — a net loss of 13 holders — while 57 trimmed existing stakes and 66 added.
The largest buyer was Broadwood Capital, adding an estimated $18.8M. The largest seller was Vanguard Group, cutting an estimated $18.1M.
- 170 institutional investors held STAAR Surgical (STAA) as of Q2 2025, down from 185 in Q1 2025.
- Funds reported $904M of STAAR Surgical stock for Q2 2025, down 1.9% quarter-over-quarter.
- 20 funds opened new STAAR Surgical positions in Q2 2025 and 33 closed out, a net change of -13 holders.
- The largest STAAR Surgical buyer in Q2 2025 was Broadwood Capital, an estimated $18.8M added.
- The largest STAAR Surgical seller in Q2 2025 was Vanguard Group, an estimated $18.1M sold.
Based on aggregated 13F filings for Q2 2025.